VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $945,772 | -18.9% | 61,654 | +25.7% | 0.04% | -18.2% |
| Q2 2023 | $1,166,447 | -11.4% | 49,031 | -5.2% | 0.04% | -20.0% |
| Q1 2023 | $1,316,444 | +51.3% | 51,747 | +73.7% | 0.06% | +19.6% |
| Q4 2022 | $870,020 | +14.5% | 29,785 | -19.5% | 0.05% | +53.3% |
| Q3 2022 | $760,000 | +146.8% | 37,015 | +39.0% | 0.03% | +130.8% |
| Q2 2022 | $308,000 | – | 26,628 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |